Microparticulated systems based on chitosan and poly(vinyl alcohol) with potential ophthalmic applications

Journal of Microencapsulation

Volumn 32, Issue 4, 2015, Pages 381-389

  Cadinoiu, Anca Niculina ^a,b   Peptu, Catalina Anisoara ^b   Fache, Bernard ^c   Chailan, Jean François ^c   Popa, Marcel ^b  

^a APOLLONIA UNIVERSITY   (Romania)

^b GHEORGHE ASACHI TECHNICAL UNIVERSITY OF IASI   (Romania)

^c UNIVERSITÉ DE TOULON   (France)

Author keywords

Chitosan; double crosslinking; microparticles; pilocarpine; poly(vinyl alcohol)

Indexed keywords

CHITOSAN; DRUG CARRIER; PILOCARPINE; POLYVINYL ALCOHOL; DELAYED RELEASE FORMULATION; EYE DROPS; MUSCARINIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CHEMICAL BOND; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG RELEASE; EYE DISEASE; HEMOCOMPATIBILITY TEST; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; LD50; MALE; MICROENCAPSULATION; MORPHOLOGICAL TRAIT; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; RAT; SUSTAINED DRUG RELEASE; SWELLING BEHAVIOR; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; HUMAN; MATERIALS TESTING; MOUSE; TOXICITY;

ANIMALS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG LIBERATION; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MATERIALS TESTING; MICE; MUSCARINIC AGONISTS; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; PILOCARPINE; POLYVINYL ALCOHOL;

EID: 84938850988     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2015.1035682     Document Type: Article

References (46)

1. Balan V, Petrache IA, Popa MI, Butnaru M, Barbu E, Tsibouklis J, Verestiuc L. Biotinylated chitosan-based SPIONs with potential in blood-contacting applications. J Nanopart Res, 2012; 14: 730-43
2. Campos E, Coimbra P, Gil MH. An improved method for preparing glutaraldehyde cross-linked chitosan-poly(vinyl alcohol) microparticles. Polymer Bull, 2013; 70: 549-61
3. Capco D, Chen Y. 2014. Nanomaterial: Impacts on cell biology and medicine. Dordrecht: Springer Science & Business Media
4. Das S, Suresh PK. Drug delivery to eye: Special reference to nanoparticles. Int J Drug Deliv, 2010; 2: 12-21
5. de la Fuente M, Ravina M, Paolicelli P, Sanchez A, Seijo B, Alonso MJ. Chitosan-based nanostructures: A delivery platform for ocular therapeutics. Adv Drug Deliver Rev, 2010; 62: 100-17
6. Dufty JMK, Craig S, Stevenson KJ, Taberner DA. Calculation of System International Sensitivity Index: How many calibrant plasmas are required? J Clin Pathol, 1997; 50: 40-4
7. Enriquez de Salamanca A, Diebold Y, Calonge M, Garcia-Vasquez C, Callejo S, Vila A, Alonso MJ. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci, 2006; 47: 1416-25
8. Gajra B, Pandya SS, Vidyasagar G, Rabari H, Dedania RR, Rao S. Poly vinyl alcohol hydrogel and its pharmaceutical and biomedical applications: A review. Int J Pharm Res 2011; 4: 20-6
9. Govindarajulu Z. 2004. Applications to biostatistics: Sequential statistics. Singapore: World Scientific
10. Guirguis OW, Moselhey MTH. Thermal and structural studies of poly(vinyl alcohol) and hydroxypropyl cellulose blends. Nat Sci, 2012; 4: 57-67
11. Hamcerencu M, Popa M, Desbrieres J, Riess G. Thermosensitive microparticles based on unsaturated esters of some poly-and oligosaccharides: Preparation, characterization, drug inclusion and release. Macromol Symp, 2010; 297: 114-25
12. Harikumar SL, Sonia A. Nanotechnological approaches in ophthalmic delivery systems. Int J Drug Dev Res, 2011; 3: 9-19
13. Hassan CM, Peppas NA. Structure and applications of poly(vinyl alcohol) hydrogels produced by conventional crosslinking of by freezing/thawing methods. Adv Polym Sci, 2000; 153: 37-65
14. Hermans K, Van den Plas D, Kerimova S, Carleer R, Adriaensens P, Weyenberg W, Ludwig A. Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A. Int Pharm, 2014; 472: 10-19
15. Im JS, Lee SK, Bai BC, Lee Y-S. Prediction and characterization of drug release in a multi-drug release system. J Ind Eng Chem, 2012; 18: 325-30
16. Jətariu Cadinoiu AN, Danu M, Peptu CA, Ioanid G, Ibanescu C, Popa M. Ionically and covalently cross-linked hydrogels based on gelatin and chitosan. Soft Mater, 2013; 11: 45-54
17. Jətariu Cadinoiu AN, Holban MN, Peptu CA, Sava A, Costuleanu M, Popa M. Double crosslinked interpenetrated network in nanoparticle form for drug targeting-Preparation, characterization and biodistribution studies. Int J Pharm, 2012; 436: 66-74
18. Kadajji VG, GV Betageri. Water soluble polymers for pharmaceutical applications. Polymers, 2011; 3: 1972-2009
19. Kanatt SR, Rao MS, Chawla SP, Sharma A. Active chitosane-polyvinyl alcohol films with natural extracts. Food Hydrocolloids, 2012; 29: 290-7
20. Kao HJ, Lin HR, Lo YL, Yu SP. Characterization of pilocarpine-loaded chitosan/carbopol nanoparticles. J Pharm Pharmacol, 2006; 58: 179-86
21. Khoo CGL, Frantzich S, Rosinski A, Sjöström M, Hoogstraate J. Oral gingival delivery systems from chitosan blends with hydrophilic polymers. Eur J Pharm Biopharm, 2003; 55: 47-56
22. Mizrahy S, Peer D. Polysaccharides as building blocks for nanotharapeutics. Chem Soc Rev, 2012; 41: 2623-40
23. Moise M, Şunel V, Holban M, Popa M, Desbrieres J, Peptu C, Lionte C. Double crosslinked chitosan and gelatin submicronic capsules entrapping aminoacid derivatives with potential antitumoral activity. J Mater Sci, 2012; 47: 8223-33
24. Nakhlaband A, Barar J. Impacts of nanomedicines in ocular pharmacotherapy. BioImpacts, 2011; 1: 7-22
25. Nayak PL, Sahoo D. Chitosan-alginate composites blended with cloisite 30B as a novel drug delivery system for anticancer drug paclitaxel. Int J Plast Technol, 2011; 15: 68-81
26. Nielsen VG, Khan ES, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin. Thromb Res, 2010; 126: 68-73
27. Parida UK, Nayak AK, Binhani BK, Nayak PL. Synthesis and characterization of chitosan-polyvinyl alcohol blended with cloisite 30B for controlled release of the anticancer drug curcumin. J Biomater Nanobiotechnol, 2011; 2: 414-25
28. Patel AR, Vavia PR. Evaluation of synthesized cross linked polyvinyl alcohol as potential disintegrant. J Pharm Pharmaceut Sci, 2010; 13: 114-27
29. Patel HA, Patel JK, Patel KN, Patel RR. Ophthalmic drug delivery system-A review. Der Pharmacia Lettre, 2010a; 2: 100-115
30. Patel MP, Patel RR, Patel JK. Chitosan mediated targeted drug delivery system: A review. J Pharm Pharmaceut Sci, 2010b; 13: 536-57
31. Peptu CA, Buhus G, Popa M, Perichaud A, Costin D. Double crosslinked chitosan-gelatin particulate systems for ophthalmic applications. J Bioact Compat Pol, 2010; 25: 98-116
32. Rathore KS, RK Nema. An insight into ophthalmic drug delivery system. Int J Pharm Sci Drug Res, 2009; 1: 1-5
33. Roy S, Pal K, Anis A, Pramanik K, Prabhakar B. Polymers in mucoadhesive drug delivery system: a brief note. Des Monomers Polym, 2009; 12: 483-95
34. Sharma PD. 2008. Environmental biology & toxicology. Meerut, Delhi: Rastogi Publications
35. Selvaraj S, Saravanakumar N, Karthikeyan J, Deborah Evangeline D, Lathamary Rajendran NN. Acyclovir loaded chitosan nanoparticles for ocular delivery. Der Pharmacia Lettre, 2010; 2: 420-31
36. Sultana Y, Jain R, Aqil M, Ali A. Review of ocular drug delivery. Curr Drug Deliv, 2006; 3: 207-17
37. Tataru G, Popa M, Costin D, Desbrieres J. Microparticles based on natural and synthetic polymers for ophthalmic applications. J Biomed Mater Res A, 2012; 100: 1209-20
38. Tataru G, Popa M, Desbrieres J. Microparticles of hydrogel type based on carboxymethylcellulose and gelatin for controlled release of water soluble drugs. Rev Roum Chim, 2011; 56: 399-410
39. Tejpal Y, Jat RK. Microspheres as an ocular drug delivery system-A review. J Drug Deliv Therap, 2013; 3: 114-23
40. Udrea LE, Hritcu D, Popa MI, Rotariu O. Preparation and characterization of polyvinyl alcohol-Chitosan biocompatible magnetic microparticles. J Magn Magn Mater, 2011; 323: 7-13
41. Vasiliu S, Popa M, Luca C. Evaluation of retention and release processes of two antibiotics from the biocompatible core-shell microparticles. Eur Polym J, 2008; 44: 3894-8
42. Wang LC, Chen XG, Zhong DY, Xu QC. Study on poly(vinyl alcohol)/carboxymethyl-chitosan blend film as local drug delivery system. J Mater Sci Mater Med, 2007; 18: 1125-33
43. Widjaja LK, Bora M, Chan PN, Lipik V, Wong TT, Venkatraman SS. Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications. J Biomed Mater Res A, 2014; 102: 3056-65
44. Yuan X, Li H, Yuan Y. Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drug to ocular surface. Carbohyd Polym, 2006; 65: 337-45
45. Yuan X, Yuan Y, Jiang W, Liu J, Tian EJ, Shun HM, Huang DH, Yuan XY, Li H, Sheng J. Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosuppression on corneal transplantation. Int J Pharm, 2008; 349: 241-8
46. Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev, 1995; 16: 61-73